A biotechnology company headquartered in France has chosen central Indiana for its second U.S.-based manufacturing facility. Orano Med plans to initially invest more than $15 million to build the facility and create a dozen jobs.... Read More
After more than a decade of work, Purdue University-based On Target Laboratories Inc. has claimed the “holy grail” of biotech startups; just days ago, the U.S. Food and Drug Administration approved CYTALUX, a surgical innovation for cervical cancer from the lab of Purdue’s Dr. Philip Low, who has launched seven companies and sold Endocyte for […]... Read More
A new material invented by a professor at the University of Notre Dame for spinal implants is likely just months away from being used on the first patients. Implants used for spinal fusion have long been made out of a polymer called PEEK, because it’s “a good material” with excellent mechanical properties, says Notre Dame […]... Read More
The biggest vaccination campaign in history is creating new pressures in logistics, and an Indianapolis-based company is responding by building a distribution facility designed specifically for the shifting demands of the life sciences industry. Langham Logistics says the new distribution center—the company’s first one north of Indianapolis—will also support a recent explosion of life sciences […]... Read More
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) is reporting fiscal full-year net income of $10.9 million, compared to a loss of $4.7 million the previous year. Chief Executive Officer Robert Leasure says the transformational year reflected the company's success in "expanding existing operations and services, starting up new services, and acquiring strategic assets."... Read More
The founder of West Lafayette-based On Target Laboratories Inc. says the recent approval from the U.S. Food and Drug Administration for the company's imaging drug Cytalux brings "a whole rainbow of emotions." Cytalux uses fluorescent technology to help surgeons spot ovarian cancer tumors. ... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research collaboration and licensing agreement with Regor Therapeutics Group, which is co-located in China and Boston. Lilly says as part of the deal, the companies will work together to discover, develop and commercialize novel therapies for metabolic disorders.... Read More
The U.S. Food and Drug Administration has expanded the Emergency Use Authorization for a combination therapy developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) to treat patients with COVID-19. Lilly says bamlanivimab and etesevimab can now be used to treat certain high-risk pediatric patients from birth to 12 years old.... Read More
Wisconsin-based Placon is celebrating the opening of its expanded medical facility in Elkhart. The Elkhart Truth reports the plastic packaging manufacturer has invested $11 million to construct the 42,000-square-foot addition and create up to 25 jobs.... Read More
The global market for 3D printed medical devices is expected to grow by $2.3 billion in the next four years, says a global technology research company. While 3D printed medical devices encompass a variety of devices, it was orthopedic and spinal 3D printing that took the largest slice of the revenue “pie” in 2020. With […]... Read More
Despite the urgency of treating a heart attack, the process of diagnosing one can seem painstakingly slow. In most cases, when a patient comes to the emergency room with symptoms of a heart attack, doctors will order a troponin test. However, the test measures a marker that can take up to six hours after a […]... Read More
An Indiana-based orthopedic powerhouse is launching the world’s first “smart” implant. Zimmer Biomet Holdings Inc.’s new Persona IQ Knee Implant is embedded with tiny sensors that—inside the patient’s knee—measure range of motion, step count, walking speed and other gait metrics. The data is delivered wirelessly to the cloud, so the patient and clinician have newfound […]... Read More
If the brilliant engineering minds at Rolls-Royce in Indianapolis know how to cool fire-hot jet engines, perhaps they could also help surmount one of the biggest challenges in the global distribution of Covid-19 vaccines: keeping them cold. The concept has crystalized into an Indiana-made freezer “pod” called ArcticRx, which its creators say can keep contents […]... Read More
The chief executive officer of Fishers-based Genezen says the Hamilton County city's central location provides an ideal environment for growth. The cell and gene therapy contract development and manufacturing organization today announced plans to... Read More
The life sciences sector in Hamilton County continues to grow. Fishers-based cell and gene therapy contract development and manufacturing organization Genezen has announced plans to invest $40 million to expand its Fishers facility and create up to 62 jobs by the end of 2023. ... Read More
Fishers Mayor Scott Fadness says the city is well on its way to becoming the “epicenter of life sciences” in the Midwest. Over the past 12 months, the Hamilton County city has welcomed more than $500... Read More
A third life sciences company has announced plans to build a laboratory and manufacturing plant in the Fishers Life Science & Innovation Park. List Biotherapeutics Inc. says it will invest more than $... Read More
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting third quarter net income of $146 million, down from $243 million during the same period last year. Chief Executive Officer Bryan Hanso... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the U.S. government has made another purchase of 614,000 doses of the combination bamlanivimab and etesevimab antibody therapy for COVID-19. As pa... Read More
A new report from BioCrossroads shows the investments from three seed funds launched over the last 15 years have proven fruitful. The Indiana Seed Funds from the state's life sciences initiative have... Read More
